Well that was interesting.
I think the statistician was the only clear person there. Even though the aim of the test to be 60% is pretty low (and I disagree that the tests they used are correct or stringent enough anyway) they now admit to having failed to reach even this with the lower CI’s only being in the 50’s. Small numbers did not help but hey closed the study at that level.
That is, the trial failed to show what they wanted it to.
- Forums
- ASX - By Stock
- TRI
- Ann: Medibio Hosts Call to Discuss Clinical Validation Study
TRI
trivarx ltd
Add to My Watchlist
0.00%
!
0.7¢

Ann: Medibio Hosts Call to Discuss Clinical Validation Study, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.338M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $6 | 921 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 2143732 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 525860 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 2005688 | 0.007 |
10 | 2488745 | 0.006 |
5 | 3240000 | 0.005 |
3 | 875498 | 0.004 |
3 | 1141670 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 525860 | 5 |
0.009 | 2803230 | 5 |
0.010 | 1400466 | 10 |
0.011 | 1720984 | 7 |
0.012 | 383440 | 2 |
Last trade - 11.15am 04/07/2025 (20 minute delay) ? |
Featured News
TRI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online